week 12- osteoporosis Flashcards

1
Q

osteopenia vs osteoporosis

decreases in bone mineral density- t score?

A

osteoporosis: T score < -2.5

osteopenia: T score -1 to -2.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

peak bone mass should be reached by 30yoa and is determined by

A

80% genetics
others: weight bearing exercise, nutrition, body mass, hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

primary vs secondary osteoporosis

A

primary: gradual and natural bone loss with aging and post menopause estrogen deficient

secondary: from other disease (i.e. anorexia, hyperthyroidism, hypogonadism, hyperparathyroidism) or medications (i.e. glucocorticoids, PPIs, chemo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 most common low impact fragility fractures from osteoporosis

A

vertebrate, hip (femoral neck), wrists

–> fall from standing or lower height; excludes major trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

which race is most osteopenic

A

asian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

major and minor risk factors for osteoprorosis

A

age >65
low BMD
white asian or hispanic
personal history of fracture
family history of osteoporosis
glucocorticoids >3months
malabsorption syndrome
hyperparathyroid
hypogonad
early menopasue (before 45)

minor:
RA
hyperthyroid
low diet Ca2+
smoking
alcohol
caffeine
weight <57kg
heparin therapy
aromatase inhibtiros

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

strongest risk factor for fracture

A

low BMD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

medications increase fracture risk

A

PPIs
anticoagulatns
aromatase inhibitors
chemo
corticosteroids
loop diuretics
SSRIs
etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

symptoms of osteoporosis

A

asymptomatic until late stages

-loss of height, kyphosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Accuracy of Physical Exam Findings for
Diagnosis of Osteoporosis

A

weight <51kg LR+ 7.3
tooth <20 LR+ 3.4
humped back LR+ 3
wall occiput >0cm LR+4.6
rib pelvis distance <2fingers LR+ 3.8
armspan height difference >5cm LR+1.6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

dx of osteoporosis

A

BMD via DXA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

indication to measure BMD for adults <50yoa

A
  • Fragility fracture
  • Prolonged use of glucocorticoids
  • Use of other high-risk medications
  • Fragility fracture after age 40 years
  • Hypogonadism or premature
    menopause (age < 45 years)
  • Malabsorption syndrome
  • Primary hyperparathyroidism
  • Other disorders strongly associated
    with rapid bone loss and/or fractur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

indication for BMD if >50yoa

A
  • Age ≥ 65 years (both men and women)
  • Clinical risk factors for fracture (menopausal women, men aged 50-64 years)
  • Fragility fracture after age 40 years
  • Prolonged use of glucocorticoids
  • Use of other high-risk medications
  • Parental hip fracture
  • Vertebral fracture or osteopenia identified on
    radiography
  • Current smoking
  • High alcohol intake
  • Low body weight (< 60 kg) or major weight loss
    (>10% of body weight at age 25 years)
  • Rheumatoid arthritis
  • Other disorders strongly associated with
    osteoporosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DXA scan for which areas

A

Lumbar spine (L2-L4), hip (femoral neck, trochanters, intertrochanteric
regions), wrist are routinely included in scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T score and Z score in a DXA scan

A

T score: standard deviations between patient BMD and mean value of MD of healthy, young, attached controls of same sex at peak bone mass (30yoa)

z score: standard deviation between patient BMD and mean value of BMD of healthy age matched control

z= AGE matched

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T scores for BMD

A
  • Normal BMD: T-score between +2.5 and -1.0
  • Osteopenia: T-score between -1.0 and -2.5
  • Osteoporosis: T-score at or below -2.5
  • Severe osteoporosis: T-score at or below -2.5 with one or
    more fragility fractures
17
Q

Z score for BMD

A
  • Z-score below -1.5 warrants a comprehensive secondary
    osteoporosis workup
18
Q

fracture risk assessment tool (FRAX)

A

predict an individual’s 10-year risk of sustaining a hip or other
major osteoporotic fracture (fragility fracture of spine, wrist,
forearm or humerus)

for 40-90yr olds not on pharmacotherapy for osteoporosis

19
Q

FRAX uses what risk factors

A

Combines clinical risk factors (age, sex, BMI, ethnicity, prior fractures,
parental hip fracture history, smoking, alcohol use, glucocorticoid use,
rheumatoid arthritis, secondary osteoporosis) and femoral neck BMD T-
score to calculate the 10-year fracture risk

20
Q

Osteoporosis Self-Assessment Tool
(OST)

A
  • Identifies individuals more likely to have low BMD
  • High risk for osteoporosis: score of <2

via =[weight (kg) - age] x 2

21
Q

CAROC (Canadian Association of
Radiologists and Osteoporosis Canada) Risk
Assessment Tool

A

Uses bone density (femoral neck T-score) and age to predict 10-year
fragility fracture risk

move up to 1 higher catgoery if hd a fragility fracture or corticosteroid use

22
Q

high risk category for CAROC

A

Two fragility fractures at a site other than hip or spine or fracture plus
corticosteroid therapy

23
Q

CAROC is based on

A

age, T score

then increase risk if History of fragility
fracture or prolonged
systemic glucocorticoid

24
Q

Male Osteoporosis Risk Estimation Score
(MORES)

A

refer for DXA if score >6

age<55 = 0
age 56-74= 3
age >75= 4
COPD= 3
weight <70kg = 6
weight 70-80kg = 4
weight >176lbs= 0

25
osteoporosis screening
Potential harms of screening: misinterpretation of test results, increasing patient anxiety, side effects of medications, cost
26
United States Preventative Task Force USPTF (2018) guidelines for osteoporosis screening :
screen if woman >65 screen if younger postmenopausal women with >9.3% 10-year risk based on the FRAX no recommendation to screen men
27
* National Osteoporosis Foundation (2014) guidelines for screening for osteoporosis
screen women >65, men >70 screen postmenopausal women and men 50-69 if FRAX and risk profile screen postmenopausal and men >50 if have adult fracture
28
additional testing for osteoporosis if have T score of -1.5 to - 2.4
* Blood urea nitrogen (BUN) * Creatinine * Albumin * Calcium – if serum calcium is abnormal, test PTH * Phosphate * Alkaline phosphatase * 25-OH vitamin D * Complete blood count
29
secondary causes of osteoporosis and testing
primary hyperparathyroid (PTH, ca, phosphorus) secondary hyperparathyroid from chronic renal failure (renal test) hyperthyroid (TSH, t3,t4) increased calcium excretion (ca and creatinine in urine) hypercortisol, aclohol, cnacer osteomalacia (vit D, ca, phosphorus)
30
imaging for osteoporosi
x ray
31
prevention of osteoprorois
smoking cessation, less alcohol, <4coffee, enough protein,vit D and Ca2+. strength training
32
when to do pharmacotherapy in osteoporosis
* Low 10-year fracture risk (<10%): unlikely to benefit from pharmacotherapy; re-assess risk in 5 years * Moderate 10-year fracture risk (10-20%): discuss therapeutic choices and consider pharmacotherapy; repeat BMD testing in 1- 3 years and reassess risk * High 10-year fracture risk (>20%): initiate pharmacotherapy
33
treatment for osteoporosis
bisphosphonates --> side effects: osteonecrosis of jaw, atypical subtrochanteric femur fracture alternatives: RANK ligand inhibitors (denosumab), selective estrogen receptor modulators (raloxifene), estrogen/progesterone hormone therapy, parathyroid hormone analogues (teriparatide), calcitonin Refer to pharmacist
34
re fracture risk
ensure timely patient follow-up after fragility fractures * Re-fracture risk is highest during the first 1-2 years after the initial fragility fracture * 50% of subsequent fractures occur within 3-5 years from the first event
35
start Treatment for osteoporosis
starting treatment in all postmenopausal women with a history of any fragility fracture patient with spine or hip fractures in addition to a low BMD